CRA International President and CEO Sells $1.4 Million Worth of Shares

On Dec. 3, 2025 CRA International CEO Paul Maleh executed an open-market sale of 7,500 shares at a weighted average price of $182.97 for approximately $1.4 million under a Rule 10b5-1 plan, representing 6.05% of his direct holdings and reducing his direct stake to 116,545 shares (about 1.78% of outstanding). CRA reported TTM revenue of $731 million and net income of $56.47 million, produced a 1-year share gain of ~16%, and recently beat quarterly expectations; analyst Kevin Steinke rates the stock a buy with a $245 target. The sale aligns with Maleh’s median recent open-market sales and is presented as routine disposition rather than a signal on company prospects.

Analysis

Market structure: Maleh’s 7,500-share 10b5-1 sale (~6% of his direct stake, 1.78% of outstanding) is immaterial to corporate control but increases available float marginally; primary beneficiaries are existing shareholders if CRAI wins high-margin mandates (e.g., FirstEnergy auction) that can lift revenue and EBITDA. Demand remains driven by litigation/engagement pipeline and momentum (stock +16–18% YTD); absent a material new issuance or major insider dump, pricing power stays with CRAI given specialized service scarcity.

Risk assessment: Tail risks include loss of a large client or a failed/controversial auction outcome that could reduce near-term revenue by 10–20% and compress EPS >20–30% (stock downside >30% in that scenario). Immediate (days) risk is headline volatility around the FirstEnergy auction; short-term (weeks–months) depends on contract wins and Qs; long-term hinges on litigation cycle secular demand, utilization of ~947 professionals, and client concentration.

Trade implications: Direct actionable strategies are small, conviction-weighted exposures: equity buys on pullbacks, covered-call income, or defined-risk option spreads. Relative ideas: express stock-specific upside versus small-cap or broad-market beta (long CRAI / short IWM) to isolate idiosyncratic performance; hedge with 3–6 month protective puts if holding through auction/earnings.

Contrarian angles: Market may be underpricing idiosyncratic upside from mandate wins and recurring expert-witness revenue; the 10b5-1 sale is routine, not a signal of deteriorating fundamentals, yet persistent scheduled insider selling (38% holding decline since Apr 2024) creates episodic supply that increases short-term volatility and buying opportunities. If insider holdings drop below 1% or CRAI misses two sequential quarters of backlog growth, the consensus bullish case should be re-evaluated.

Key Decisions for Investors

• Initiate a 2–3% portfolio long position in CRAI (CRAI) staggered 50/50 now and on a 5–10% pullback; target exit/trim at +12–18% or if position falls -12% from entry (tighten to -8% if unhedged).
• If already long, sell 1–2% covered-call exposure (30–60 day LEAPs) at strikes 10–15% OTM to harvest premium; alternatively implement a 3–6 month collar (long stock, sell 10–15% OTM call, buy 8–12% OTM put) to cap downside through the next auction/quarterly report.
• Express idiosyncratic bullishness with limited option risk: buy a 3–6 month call spread (e.g., buy ATM, sell +15% OTM) sized to 1% portfolio risk to capture analyst-target-driven upside to $245 within 6–9 months.
• Pair trade to isolate stock-specific alpha: go long CRAI and short IWM (Russell 2000 ETF) sized dollar-neutral to remove market beta; rebalance within 2–6 weeks post-FirstEnergy auction outcome and trim if CRAI’s backlog/revenue does not increase by >5% QoQ.